Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,542 JPY | +1.60% | +0.67% | +33.44% |
Apr. 12 | Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million. | CI |
Apr. 12 | Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. | CI |
Business Summary
Number of employees: 1,011
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Formulation
57.9
%
| 23,703 | 54.5 % | 26,097 | 57.9 % | +10.10% |
Drug Substance
41.6
%
| 19,481 | 44.8 % | 18,783 | 41.6 % | -3.58% |
Healthy Food
0.5
%
| 279 | 0.6 % | 220 | 0.5 % | -21.15% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 43,464 | 100.0 % | 45,101 | 100.0 % | +3.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kiyotaka Kido
PSD | President | - | - |
Eiichi Takada
CTO | Chief Tech/Sci/R&D Officer | - | - |
Masuo Nomura
ADM | Chief Administrative Officer | - | - |
Director/Board Member | 67 | 23-06-30 | |
Kazushige Hizume
BRD | Director/Board Member | 62 | 85-03-31 |
Junichi Kikuta
BRD | Director/Board Member | 74 | 10-02-28 |
Michio Tsuda
BRD | Director/Board Member | 76 | 71-03-31 |
Yasunobu Otsuga
BRD | Director/Board Member | 73 | 75-02-28 |
Radomir Gibala
PRN | Corporate Officer/Principal | - | Dec. 31 |
Masahiro Harai
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yasunobu Otsuga
BRD | Director/Board Member | 73 | 75-02-28 |
Michio Tsuda
BRD | Director/Board Member | 76 | 71-03-31 |
Hitoshi Hori
BRD | Director/Board Member | 70 | 99-01-31 |
Junichi Kikuta
BRD | Director/Board Member | 74 | 10-02-28 |
Kiyotaka Kido
PSD | President | - | - |
Kazumi Yamamoto
BRD | Director/Board Member | 67 | 12-07-31 |
Atsushi Saino
BRD | Director/Board Member | 50 | 16-07-31 |
Kazushige Hizume
BRD | Director/Board Member | 62 | 85-03-31 |
Director/Board Member | 67 | 23-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 15,698,440 | 12,566,706 ( 80.05 %) | 55,050 ( 0.3507 %) | 80.05 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
DAIICHI SANKYO CO., LTD. 0.01% | 163,500 | 0.01% | 5,160,657 $ |
80,400 | 0.00% | 2,498,406 $ | |
61,100 | 0.00% | 1,689,137 $ | |
80,000 | 0.02% | 1,297,433 $ | |
181,037 | 0.28% | 1,141,163 $ | |
41,500 | 0.09% | 948,485 $ | |
19,200 | 0.04% | 764,981 $ | |
RIKEN VITAMIN CO., LTD. 0.12% | 39,200 | 0.12% | 667,730 $ |
30,300 | 0.06% | 581,395 $ | |
35,905 | 0.03% | 459,770 $ |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.44% | 250M | |
+20.33% | 43.95B | |
+22.22% | 22.49B | |
+14.56% | 14.71B | |
+10.81% | 13.77B | |
+42.35% | 12.3B | |
-8.70% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.75% | 5.48B |
- Stock Market
- Equities
- 4577 Stock
- Company Daito Pharmaceutical Co.,Ltd.